All practice questions

8270 questions

Question 341Question →

A 59-year-old postmenopausal woman with a family history of breast cancer and a recently confirmed BRCA1 pathogenic variant presents to her physician with early satiety, bloating, and increasing abdominal girth for the past month. Physical examination reveals a palpable, fixed, irregular left adnexal mass and a clinically detectable fluid wave indicating ascites. Arrange the following steps in the most appropriate chronological order for the diagnostic workup and standard management of this patient, from initial evaluation to post-remission therapy.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is: Pelvic ultrasonography, followed by CT scan and CA-125, then Surgical cytoreduction, followed by Adjuvant chemotherapy, and concluding with PARP inhibitor maintenance.
The standard diagnostic and therapeutic pathway for suspected advanced ovarian cancer begins with transvaginal ultrasonography, which is the most sensitive initial imaging modality to characterize adnexal pathology. Following sonographic confirmation of a suspicious mass, a CT scan of the chest, abdomen, and pelvis along with serum CA-125 is necessary for pre-operative staging and assessing surgical resectability. The primary therapeutic intervention is then an exploratory laparotomy for maximal surgical cytoreduction (debulking), followed by adjuvant systemic platinum-based and taxane-based chemotherapy. Finally, in a patient with a confirmed BRCA mutation who has completed primary chemotherapy and achieved a response, maintenance therapy with a PARP inhibitor is indicated to substantially prolong progression-free survival.

Step-by-Step Solution

1
Identify the most appropriate initial diagnostic test for a suspected adnexal mass.
Pelvic ultrasonography is placed first.
Ultrasound is the primary modality to characterize adnexal masses and determine the initial risk of malignancy based on sonographic architecture.
2
Determine the necessary preoperative evaluation for a highly suspicious adnexal mass with ascites.
CT of the chest, abdomen, and pelvis with serum CA-125 is placed second.
Cross-sectional imaging is required to evaluate the extent of intra-abdominal and extra-abdominal metastasis to plan for surgical resectability.
3
Identify the primary therapeutic intervention.
Exploratory laparotomy for maximal surgical cytoreduction is placed third.
Surgical debulking is the standard of care for the primary treatment of advanced ovarian cancer, unless the disease is deemed entirely unresectable.
4
Select the appropriate post-surgical management.
Adjuvant systemic chemotherapy is placed fourth.
Platinum- and taxane-based chemotherapy is universally indicated following cytoreduction to eliminate residual disease in advanced ovarian carcinoma.
5
Identify the role of targeted therapy based on the patient's specific genetic profile.
PARP inhibitor maintenance therapy is placed last.
Because the patient has a known BRCA1 mutation, PARP inhibitor therapy is indicated strictly as maintenance after the completion of primary chemotherapy.

Key Concept

The standard chronological management of advanced epithelial ovarian cancer involves initial ultrasound evaluation, preoperative CT staging, maximal surgical cytoreduction, adjuvant platinum-based chemotherapy, and targeted maintenance therapy for patients with a BRCA mutation.
Question 342Question →

A 24-year-old nulliparous woman presents to the clinic reporting that she has not had a menstrual period for the past 6 months. Her menarche occurred at age 12, and her menses were previously regular, occurring every 28 days. She takes no medications, has no chronic medical conditions, and is sexually active with a male partner. Her vital signs and physical examination are unremarkable. Arrange the following diagnostic steps in the most appropriate chronological sequence for the evaluation of this patient's secondary amenorrhea, starting with the immediate first step.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

1) Urine beta-hCG test, 2) Serum prolactin, TSH, and FSH levels, 3) Progestin withdrawal challenge, 4) Estrogen-progestin challenge test
The evaluation of secondary amenorrhea must follow a stepwise algorithmic approach to avoid unnecessary testing and misdiagnosis. First, a pregnancy test is universally mandatory for any woman of reproductive age presenting with amenorrhea. Second, initial laboratory evaluation with TSH, prolactin, and FSH identifies the most common systemic neuroendocrine causes, such as hypothyroidism, pituitary adenomas, or premature ovarian insufficiency. Third, a progestin challenge assesses for adequate endogenous estrogen production; if bleeding occurs, it confirms anovulation with adequate estrogen. Finally, if there is no withdrawal bleeding, an estrogen-progestin challenge distinguishes between a profound lack of estrogen (bleeding occurs) and an anatomic outflow tract obstruction such as Asherman syndrome (no bleeding occurs).

Step-by-Step Solution

1
Perform a urine beta-hCG test
Excludes pregnancy
Pregnancy must always be ruled out first in secondary amenorrhea, regardless of contraceptive use or patient history.
2
Measure serum prolactin, TSH, and FSH
Evaluates for systemic endocrine causes
Identifies common etiologies like hyperprolactinemia, hypothyroidism, and primary ovarian insufficiency.
3
Administer a progestin withdrawal challenge
Assesses endogenous estrogen levels
Determines if the endometrium has been sufficiently primed by endogenous estrogen to produce withdrawal bleeding.
4
Administer an estrogen-progestin challenge
Differentiates hypoestrogenism from outflow tract obstruction
If bleeding occurs after estrogen and progestin, the amenorrhea is due to low estrogen; if no bleeding occurs, an anatomic defect (like Asherman syndrome) is present.

Key Concept

The algorithmic approach to diagnosing secondary amenorrhea begins unconditionally with excluding pregnancy, followed by identifying common endocrine abnormalities, and subsequently assessing the hypothalamic-pituitary-ovarian axis and outflow tract integrity.
Question 343Question →

A 26-year-old woman evaluates at the urgent care center due to four days of copious, malodorous vaginal discharge associated with mild dysuria. Her medical history is unremarkable, and she recently became sexually active with a new male partner. Her temperature is 37.1∘C37.1^\circ\text{C} (98.8∘F98.8^\circ\text{F}). Speculum examination demonstrates frothy, yellow-green fluid pooled in the posterior vaginal fornix and several punctate macular hemorrhages on the cervix. A saline microscopy preparation of the fluid reveals multiple motile, pear-shaped, flagellated organisms slightly larger than polymorphonuclear leukocytes. Which of the following is the most appropriate pharmacological intervention?

Show answer & explanation

Answer: Prescribe oral metronidazole for the patient and concurrently treat her sexual partner

Answer

Prescribe oral metronidazole for the patient and concurrently treat her sexual partner.
The patient's presentation of a malodorous, frothy, yellow-green discharge, punctate cervical hemorrhages (colpitis macularis or 'strawberry cervix'), and motile flagellated organisms on a wet mount is definitively diagnostic of an infection with Trichomonas vaginalis. Because trichomoniasis is a sexually transmitted infection, systemic oral therapy (such as metronidazole) must be prescribed. Furthermore, it is critical to concurrently treat the patient's sexual partner(s) to eradicate the reservoir and prevent 'ping-pong' reinfection.

Step-by-Step Solution

1
Identify the pathogen based on the clinical signs and microscopic findings.
The combination of frothy, yellow-green discharge, a 'strawberry cervix' (colpitis macularis), and motile flagellated organisms is diagnostic for Trichomonas vaginalis.
Accurate identification of the organism is required to select the correct targeted antimicrobial therapy.
2
Determine the optimal pharmacological treatment for the identified pathogen.
Systemic oral metronidazole (or tinidazole) is the first-line treatment.
Systemic therapy is necessary because Trichomonas often infects the urethra and paravaginal glands where topical treatments cannot reach.
3
Determine if partner treatment is necessary based on the transmission route.
Concurrent treatment of all sexual partners is required.
Trichomoniasis is a highly contagious sexually transmitted infection; untreated partners will continuously reinfect the patient.

Key Concept

Diagnosis and management of Trichomoniasis, emphasizing the necessity of expedited partner therapy.
Question 344Question →

Review the following four patient profiles. Each patient is seeking a reliable method of contraception. Match each clinical scenario with the most medically appropriate contraceptive method based on the United States Medical Eligibility Criteria (US MEC) for Contraceptive Use.

Click a left item, then click its matching right item

Items

A 35-year-old woman with active estrogen receptor-positive breast cancer currently undergoing adjuvant tamoxifen therapy.
A 29-year-old woman with a history of a Roux-en-Y gastric bypass procedure two years ago, who reports severe baseline dysmenorrhea and heavy menstrual bleeding.
A 24-year-old woman taking phenytoin for generalized tonic-clonic seizures, who requests a highly effective, non-daily, non-intrauterine hormonal contraceptive.
A 38-year-old woman who smokes 20 cigarettes per day and specifically requests a daily oral contraceptive.

Matches

Show answer & explanation

Answer

The breast cancer patient receives the Copper IUD; the bariatric surgery patient receives the Levonorgestrel IUS; the patient on phenytoin receives the DMPA injection; and the 38-year-old smoker receives the Progestin-only pill.
Each assignment rigorously adheres to the US MEC guidelines. The Copper IUD avoids hormone exposure in active breast cancer; the LNG-IUS bypasses gastric malabsorption while treating dysmenorrhea; the DMPA injection provides sufficient hormone levels to overcome hepatic enzyme induction by phenytoin; and the progestin-only pill provides a requested oral method while avoiding the severe cardiovascular risks of estrogen in older smokers.

Step-by-Step Solution

1
Analyze the contraindications for the 35-year-old patient with breast cancer on tamoxifen.
Identify that all hormonal methods (both estrogen and progestin) are strictly contraindicated (MEC 4).
Current or recent breast cancer requires completely hormone-free contraception, making the Copper IUD the only appropriate choice among the options.
2
Evaluate the contraceptive needs of the 29-year-old patient with prior Roux-en-Y gastric bypass and dysmenorrhea.
Rule out oral contraceptives due to malabsorption (MEC 3) and select the Levonorgestrel-releasing IUS.
Non-oral systemic or local methods are required post-malabsorptive bariatric surgery. The levonorgestrel IUS is uniquely suited to treat her comorbid heavy bleeding and severe dysmenorrhea.
3
Assess the pharmacokinetic interactions for the 24-year-old on phenytoin.
Determine that phenytoin induces hepatic enzymes, reducing the efficacy of most hormonal methods, but select the DMPA injection.
DMPA maintains its efficacy despite enzyme induction due to its high systemic dose. It perfectly satisfies her request for a highly effective, non-daily, non-intrauterine method.
4
Apply age and lifestyle criteria to the 38-year-old smoker.
Recognize that combined oral contraceptives are contraindicated (MEC 4) and assign the Progestin-only pill.
Women over age 35 who smoke heavily (>= 15 cigarettes/day) have an unacceptably high risk of thromboembolism and myocardial infarction with estrogen. Since she specifically requested a pill, the progestin-only formulation is the correct choice.

Key Concept

Application of the US Medical Eligibility Criteria (MEC) for Contraceptive Use in patients with complex medical comorbidities, including malignancy, malabsorption, enzyme-inducing medications, and cardiovascular risk factors.
Question 345Question →

A 27-year-old female presents to the outpatient clinic reporting an absence of menstruation for the past seven months. She previously experienced predictable cycles every 29 days. She denies hot flashes, nipple discharge, vision changes, or recent alterations in body weight. Physical examination shows a normal female escutcheon, no signs of hyperandrogenism, and an unremarkable bimanual pelvic examination. Arrange the following diagnostic steps in the most appropriate sequential order for evaluating this patient's condition, starting with the mandatory initial test.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is: 1) Human chorionic gonadotropin assay, 2) Thyrotropin, prolactin, and follicle-stimulating hormone evaluation, 3) Progestin withdrawal challenge, 4) Sequential estrogen and progestin administration.
The evaluation of secondary amenorrhea follows a logical, step-wise algorithm to isolate the underlying etiology. Because pregnancy is the most common cause of secondary amenorrhea, a human chorionic gonadotropin (hCG) assay is the mandatory first step. Once pregnancy is excluded, the clinician should measure serum thyrotropin (TSH), prolactin, and follicle-stimulating hormone (FSH) to identify hypothyroidism, hyperprolactinemia, and primary ovarian insufficiency or functional hypothalamic amenorrhea, respectively. If these initial screening laboratories are normal, a progestin challenge test (e.g., a short course of medroxyprogesterone acetate) is administered to assess the patient's endogenous estrogen status and the patency of the genital outflow tract. A patient with adequate estrogen will experience withdrawal bleeding. If no bleeding occurs, an estrogen-progestin challenge is performed to prime the endometrium. Bleeding after this combination indicates a hypoestrogenic state, whereas a continued absence of bleeding points to an anatomical outflow tract obstruction (e.g., Asherman syndrome).

Step-by-Step Solution

1
Exclude pregnancy
Human chorionic gonadotropin (hCG) testing is performed.
Pregnancy is the most common cause of secondary amenorrhea and must always be the first condition ruled out.
2
Assess for common endocrine disorders
Serum levels of thyrotropin (TSH), prolactin, and follicle-stimulating hormone (FSH) are measured.
This identifies central or peripheral endocrine issues such as hypothyroidism, hyperprolactinemia, and primary ovarian insufficiency.
3
Evaluate endogenous estrogen and outflow tract
A progestin challenge test is administered.
Withdrawal bleeding confirms adequate endogenous estrogen and a patent outflow tract. Lack of bleeding requires further testing to determine the cause.
4
Differentiate hypoestrogenism from anatomical obstruction
An estrogen-progestin challenge is administered.
Bleeding indicates the outflow tract is patent but the patient is hypoestrogenic. Lack of bleeding confirms an outflow tract obstruction, such as Asherman syndrome.

Key Concept

The step-wise diagnostic evaluation of secondary amenorrhea begins with excluding pregnancy, followed by initial endocrine screening (TSH, prolactin, FSH), and then sequential hormonal challenges to evaluate the hypothalamic-pituitary-ovarian axis and uterine outflow tract.
Estimated Time:1m 30s
Question 346Question →

Evaluate the following complex patient profiles. Match each clinical scenario with the single most appropriate, highly effective contraceptive method based on the WHO/CDC Medical Eligibility Criteria (MEC).

Click a left item, then click its matching right item

Items

A 29-year-old woman with systemic lupus erythematosus and a history of deep vein thrombosis. Laboratory testing confirms the presence of lupus anticoagulant. She has regular, normal-volume menstrual periods.
A 39-year-old woman who smokes 20 cigarettes daily. She is currently admitted to the hospital receiving intravenous antibiotics for an acute tubo-ovarian abscess.
A 42-year-old woman with a blood pressure of 155/95 mmHg, severe heavy menstrual bleeding causing anemia, and a documented history of Wilson disease.
A 26-year-old woman with sickle cell disease and epilepsy managed with phenytoin. Pelvic ultrasound reveals a 5-cm submucosal leiomyoma significantly distorting the uterine cavity.

Matches

Show answer & explanation

Answer

The correct matches are: SLE/Antiphospholipid patient → Copper IUD; 39-year-old smoker with PID → Etonogestrel implant; Hypertensive with Wilson disease → Levonorgestrel IUD; Phenytoin user with distorted cavity → Depot medroxyprogesterone acetate.
Each clinical scenario requires the synthesis of at least two competing contraindications. The SLE patient with lupus anticoagulant requires a hormone-free method (Copper IUD) due to severe thrombophilia. The smoker with an active tubo-ovarian abscess cannot safely receive estrogen or an IUD, leaving the subdermal implant. The hypertensive patient with Wilson disease requires an LNG-IUD for medical management of bleeding while avoiding copper and estrogen. The patient on phenytoin with a distorted cavity requires DMPA to bypass both hepatic enzyme induction and anatomic constraints.

Step-by-Step Solution

1
Evaluate the systemic lupus erythematosus (SLE) patient with antiphospholipid antibodies.
Identify that both estrogen (MEC 4) and progestin-only methods (MEC 3) are restricted due to severe thrombophilia risk.
This leaves the non-hormonal Copper IUD as the only highly effective, MEC 1 option.
2
Evaluate the 39-year-old smoker with active pelvic inflammatory disease (PID).
Identify that age >35 plus smoking >15 cigarettes/day contraindicates estrogen (MEC 4), and active PID contraindicates IUD initiation (MEC 4).
This leaves the etonogestrel subdermal implant as the optimal MEC 1 option.
3
Evaluate the hypertensive patient with heavy bleeding and Wilson disease.
Identify that hypertension contraindicates estrogen (MEC 3), while Wilson disease strictly contraindicates the Copper IUD (MEC 4).
The levonorgestrel IUD is MEC 1 for hypertension, treats the heavy menstrual bleeding, and contains no copper.
4
Evaluate the patient taking phenytoin with a distorted uterine cavity.
Identify that phenytoin (CYP450 inducer) reduces the efficacy of most systemic hormones (MEC 3), and a distorted cavity contraindicates all IUDs (MEC 4).
Depot medroxyprogesterone acetate (DMPA) bypasses hepatic enzyme induction to maintain efficacy and is unaffected by uterine anatomy.

Key Concept

Advanced application of the Medical Eligibility Criteria (MEC) for contraceptive use in patients with overlapping medical comorbidities, anatomic abnormalities, and drug interactions.
Estimated Time:2m 0s
Question 347Question →

A 24-year-old healthy female presents to the clinic reporting an absence of menses for the past six months. She previously had regular 28-day menstrual cycles. She does not take any medications, has no chronic medical conditions, and reports no breast discharge, visual changes, or hot flashes. Physical examination reveals a normal body mass index and normal secondary sexual characteristics. Arrange the following diagnostic steps in the most appropriate chronological sequence for the initial evaluation of this patient's secondary amenorrhea, starting with the most immediate first step.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is: beta-hCG testing, followed by TSH and prolactin measurement, then a progestin withdrawal test, and finally an FSH assessment.
The algorithm for secondary amenorrhea mandates a logical, cost-effective progression. Pregnancy is ruled out first because it is the most common etiology. Next, easily treatable systemic conditions (thyroid and pituitary adenomas) are evaluated via TSH and prolactin. Once these are excluded, the progestin challenge determines if the ovaries are producing estrogen. Only if estrogen is lacking (no withdrawal bleed) is FSH required to determine if the failure is at the level of the ovary or the brain.

Step-by-Step Solution

1
Exclude pregnancy.
Beta-hCG test is ordered as the first step.
Pregnancy is the most prevalent cause of secondary amenorrhea in women of reproductive age. It must always be ruled out before any other diagnostics or hormonal treatments are initiated.
2
Evaluate for common endocrine disorders.
TSH and prolactin levels are drawn.
Thyroid disorders and hyperprolactinemia are frequent, easily identifiable, and highly treatable causes of secondary amenorrhea that can disrupt the hypothalamic-pituitary-ovarian axis.
3
Assess estrogen status and outflow tract patency.
A progestin withdrawal test (e.g., a 10-day course of medroxyprogesterone acetate) is administered.
Withdrawal bleeding confirms adequate endogenous estrogen production and an intact outflow tract (typical of anovulation/PCOS). Absence of bleeding indicates hypoestrogenism or an anatomic abnormality.
4
Localize the defect if the progestin challenge is negative.
FSH levels are checked.
Measuring FSH distinguishes between an ovarian etiology (hypergonadotropic hypogonadism, high FSH) and a hypothalamic/pituitary etiology (hypogonadotropic hypogonadism, low/normal FSH).

Key Concept

The stepwise evaluation of secondary amenorrhea always begins with a pregnancy test, followed by systemic endocrine screening (TSH/Prolactin), and subsequent anatomic/estrogen evaluation using hormonal challenges and gonadotropin levels.
Question 348Question →

A 2626-year-old nulligravid woman presents to the gynecologist reporting the absence of menses for the past 66 months. Prior to this, she had regular menstrual cycles occurring every 2828 days. Over the same 66-month period, she has noted a significant increase in thick, dark hair on her face, chest, and abdomen, as well as a noticeable deepening of her voice. She has also experienced a receding hairline. She has no significant past medical history and takes no medications or supplements. Vital signs are within normal limits. Her BMI is 23 kg/m223 \text{ kg/m}^2. Physical examination reveals temporal balding, severe hirsutism on the face and trunk, and clitoromegaly. Bimanual pelvic examination is limited by patient discomfort but reveals no obvious adnexal masses. A urine human chorionic gonadotropin test is negative. Serum thyroid-stimulating hormone (TSH) and prolactin levels are within normal limits. Which of the following is the most appropriate next step in the evaluation of this patient?

Show answer & explanation

Answer: Measurement of serum testosterone and dehydroepiandrosterone sulfate

Answer

Measurement of serum testosterone and dehydroepiandrosterone sulfate
The correct next step is the measurement of serum testosterone and dehydroepiandrosterone sulfate (DHEAS). This patient presents with secondary amenorrhea and rapid-onset, severe hyperandrogenism leading to frank virilization (evidenced by clitoromegaly, deepening of the voice, and temporal balding). While mild, chronic hirsutism is commonly caused by polycystic ovary syndrome (PCOS) or non-classic congenital adrenal hyperplasia (NCCAH), rapid-onset virilization is a major red flag for an androgen-secreting neoplasm. These tumors can arise from the ovaries (e.g., Sertoli-Leydig cell tumors) or the adrenal glands (e.g., adrenal adenoma or carcinoma). Measuring serum testosterone and DHEAS helps differentiate the source: markedly elevated testosterone points to an ovarian etiology, whereas markedly elevated DHEAS points to an adrenal etiology.

Step-by-Step Solution

1
Identify the patient's primary presenting syndrome.
The patient has secondary amenorrhea accompanied by rapid-onset (66 months) severe hyperandrogenism, characterized by frank virilization (clitoromegaly, deepening voice, male-pattern balding).
Recognizing the severity and tempo of hyperandrogenism is critical for narrowing the differential diagnosis.
2
Differentiate between benign and neoplastic causes of hyperandrogenism.
Benign causes like polycystic ovary syndrome (PCOS) and non-classic congenital adrenal hyperplasia (NCCAH) typically present with a slow, insidious onset of mild to moderate hirsutism and acne, lacking frank virilization. Rapid-onset virilization strongly suggests an androgen-secreting neoplasm.
This distinction prevents misdiagnosis of common conditions like PCOS in patients harboring a potentially life-threatening tumor.
3
Determine the necessary laboratory tests to identify the source of the suspected neoplasm.
Measurement of serum total testosterone and dehydroepiandrosterone sulfate (DHEAS) is indicated.
Markedly elevated testosterone levels (typically >150 ng/dL150 \text{ ng/dL}) suggest an ovarian source (e.g., Sertoli-Leydig cell tumor), whereas markedly elevated DHEAS levels (typically >700 mcg/dL700 \text{ mcg/dL}) suggest an adrenal source (e.g., adrenal adenoma or carcinoma).

Key Concept

Rapid-onset hirsutism with signs of virilization (such as clitoromegaly, temporal balding, and deepening of the voice) requires immediate evaluation for an androgen-secreting tumor of ovarian or adrenal origin using serum testosterone and DHEAS levels.
Question 349Question →

A 27-year-old primigravid woman at 39 weeks gestation is admitted to the labor and delivery unit in spontaneous labor. She requests and receives epidural anesthesia for pain management. Her labor progresses without complication, and her cervix becomes completely dilated. She is instructed to begin pushing. Three hours later, a vaginal examination reveals the cervix is 10 cm dilated and 100% effaced, and the fetal head is at +2 station in the direct occiput anterior position. The maternal temperature is 37.1°C (98.8°F), blood pressure is 118/76 mm Hg, and pulse is 84/min. Uterine contractions occur every 2 to 3 minutes and are strong to palpation. Continuous fetal heart rate monitoring demonstrates a baseline of 135/min, moderate variability, and symmetric, gradual decreases in the fetal heart rate that begin and end with each uterine contraction. The nadir of these decreases coincides precisely with the peak of each contraction. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Continued maternal pushing

Answer

The correct answer is continued maternal pushing.
The correct answer is continued maternal pushing because the patient has not yet met the diagnostic criteria for second-stage labor arrest. According to current American College of Obstetricians and Gynecologists (ACOG) guidelines, an arrest of the second stage in a nulliparous woman with epidural anesthesia is diagnosed only after at least 4 hours of pushing. Because she has been pushing for 3 hours, has adequate contractions, and has a Category I fetal heart rate tracing (baseline 135/min, moderate variability, and early decelerations due to head compression), the most appropriate management is to allow her to continue pushing.

Step-by-Step Solution

1
Interpret the fetal heart rate (FHR) tracing to determine fetal status.
The FHR shows a normal baseline, moderate variability, and early decelerations (gradual decreases that mirror the contractions). This is a reassuring Category I tracing.
Early decelerations are a benign result of fetal head compression during the second stage of labor and do not require intervention.
2
Assess the adequacy of uterine contractions.
Contractions are occurring every 2 to 3 minutes and are palpated as strong, indicating adequate uterine activity.
This rules out the need for uterotonic augmentation (e.g., oxytocin).
3
Apply the diagnostic criteria for second-stage arrest based on parity and epidural status.
The patient is a nulliparous woman with an epidural. Current guidelines define second-stage arrest in this population as the lack of progress after 4 hours of pushing.
Since she has only been pushing for 3 hours, she has not yet met the criteria for an arrest disorder.
4
Determine the next best step in management.
Expectant management with continued maternal pushing.
Because both maternal and fetal statuses are reassuring and the patient is within the normal temporal limits for the second stage of labor, no medical or surgical intervention is indicated at this time.

Key Concept

The diagnosis of second-stage arrest of labor requires specific time limits: at least 4 hours of pushing in nulliparous women with an epidural (or 3 hours without), and at least 3 hours in multiparous women with an epidural (or 2 hours without).
Question 350Question →

Match the following patient clinical profiles with the most appropriate next step in management.

Click a left item, then click its matching right item

Items

70-year-old man, 3 weeks post-myocardial infarction, meeting criteria for major depressive disorder.
28-year-old woman in her first trimester of pregnancy with psychotic depression and refusal of oral intake.
40-year-old man with major depressive disorder, experiencing persistent sexual dysfunction and fatigue on an SSRI.
25-year-old woman with major depressive disorder characterized by prominent insomnia and significant weight loss.
22-year-old man with severe depression and a history of a 7-day period of euphoric mood, grandiosity, and decreased need for sleep.

Matches

Show answer & explanation

Answer

The most appropriate management strategies are matched as follows: the post-myocardial infarction patient with sertraline, the pregnant patient with psychotic depression with urgent electroconvulsive therapy, the patient with SSRI-induced sexual dysfunction with bupropion augmentation, the patient with insomnia and weight loss with mirtazapine, and the patient with a history of mania with quetiapine.
The correct matches align specific interventions with the unique clinical presentations of each patient, ensuring efficacy while minimizing risks and addressing prominent side effects or symptoms.

Step-by-Step Solution

1
Assess the cardiovascular risk profile of the 70-year-old man.
Identify that a post-myocardial infarction status requires a medication with high cardiac safety.
Tricyclic antidepressants and some SSRIs can cause arrhythmias or interact with cardiac medications; sertraline is proven safe.
2
Evaluate the acuity of the 28-year-old pregnant woman.
Determine that psychosis and food refusal necessitate a rapid, life-saving intervention.
Electroconvulsive therapy is highly effective and safe for both the mother and fetus in psychiatric emergencies.
3
Analyze the side effect burden of the 40-year-old man.
Recognize that SSRI-induced sexual dysfunction and residual fatigue require a mechanism change.
Adding an NDRI like bupropion targets these specific residual symptoms without compounding sexual dysfunction.
4
Identify the prominent neurovegetative symptoms in the 25-year-old woman.
Select an agent that promotes sleep and appetite.
Mirtazapine's antagonism of H1 receptors directly treats her insomnia and weight loss.
5
Recognize the past manic episode in the 22-year-old man's history.
Diagnose bipolar I depression and select an appropriate mood-stabilizing agent.
Quetiapine treats bipolar depression while avoiding the risk of a manic switch associated with SSRI monotherapy.

Key Concept

Tailoring the pharmacological and procedural management of depressive disorders requires careful consideration of medical comorbidities, prominent symptom profiles, clinical acuity, and past psychiatric history.
Estimated Time:1m 30s
Question 351Question →

Diagnostic boundaries in psychiatry often hinge on precise symptom duration and the exact nature of the triggering event. For each of the following patient encounters, determine the single most appropriate DSM-5 diagnosis by differentiating between overlapping clinical features.

Click a left item, then click its matching right item

Items

A 22-year-old man avoids attending university lectures and eating in the cafeteria due to intense palpitations and sweating. He is terrified that others will notice his hands shaking and judge him as weak. He is completely comfortable in densely crowded places, such as large music festivals, as long as he remains anonymous.
A 45-year-old woman presents with severe muscle tension, fatigue, and insomnia. For the past 7 months, she has been unable to control her excessive worry concerning her husband's health, her work performance, and minor home maintenance. Her husband had a mild myocardial infarction 8 months ago, but her anxiety has since generalized to unrelated domains.
A 30-year-old paramedic responded to a catastrophic multi-vehicle collision 25 days ago. He reports experiencing intrusive visual memories of the scene, marked physiological reactivity when hearing sirens, and an inability to experience positive emotions. He now takes a longer route to work to avoid the highway.
A 29-year-old woman was unexpectedly terminated from her corporate job 4 months ago. She experiences recurrent, distressing thoughts about the day she was fired, avoids driving past her former office building, feels socially detached, and has severe insomnia. She frequently states her life is permanently ruined.
A 38-year-old woman has spent the past year avoiding flying on airplanes, traveling on subways, and visiting enclosed shopping malls. She has never had a full panic attack, but she is terrified of suddenly developing incapacitating, panic-like symptoms (such as dizziness or loss of bowel control) and being unable to escape or obtain help.

Matches

Show answer & explanation

Answer

The clinical vignettes demonstrate subtle diagnostic boundaries. The correct matches are: the student avoiding lectures has Social Anxiety Disorder; the woman with multi-domain worry has Generalized Anxiety Disorder; the paramedic at 25 days post-trauma has Acute Stress Disorder; the fired corporate worker has Adjustment Disorder; and the woman avoiding travel has Agoraphobia.
Each diagnosis is established by strictly applying DSM-5 exclusionary criteria. Social Anxiety Disorder involves fear of scrutiny. GAD requires more than 6 months of multi-domain worry. Acute Stress Disorder is restricted to trauma symptoms lasting less than 1 month. Adjustment Disorder applies to significant distress from non-Criterion A stressors. Agoraphobia involves fear of entrapment without necessitating recurrent unexpected panic attacks.

Step-by-Step Solution

1
Identify the core underlying fear in each vignette.
Fear of social scrutiny indicates Social Anxiety Disorder, while fear of being trapped with incapacitating symptoms indicates Agoraphobia.
Differentiating anxiety disorders requires isolating the primary cognitive distortion driving the avoidance behavior.
2
Determine if the precipitating stressor meets DSM-5 Criterion A for trauma.
Job loss does not involve actual or threatened death, serious injury, or sexual violence, defaulting the diagnosis to Adjustment Disorder despite the severity of the reaction.
PTSD and Acute Stress Disorder cannot be diagnosed without a qualifying Criterion A trauma.
3
Evaluate the exact timeline of the presenting symptoms.
Trauma-related symptoms lasting less than 1 month (25 days) indicate Acute Stress Disorder, while generalized worry spanning multiple domains for more than 6 months confirms Generalized Anxiety Disorder.
Psychiatric diagnoses frequently change based entirely on duration thresholds.

Key Concept

Accurate psychiatric diagnosis requires strict adherence to DSM-5 criteria regarding the precise duration of symptoms, the specific definition of a Criterion A trauma, and the patient's core underlying fear.
Question 352Question →

A 75-year-old man is brought to the clinic by his daughter for a cognitive evaluation. Over the past 5 months, he has stopped managing his finances, spends most of the day sitting in a recliner, and frequently complains that his memory is 'completely gone.' When the physician asks him to perform serial sevens and recall three objects, he sighs loudly, states 'I just cannot do this anymore,' and refuses to try. Five months ago, he was forced to surrender his driver's license due to worsening macular degeneration. His daughter notes that he has lost 4.5 kg (10 lb) during this period. Neurologic examination is nonfocal. Which of the following is the most likely diagnosis?

Show answer & explanation

Answer: Major depressive disorder

Answer

Major depressive disorder
This patient is presenting with cognitive impairment secondary to major depressive disorder, a clinical picture often referred to as 'pseudodementia.' In the elderly, depression frequently manifests with prominent memory complaints. Key features that differentiate pseudodementia from genuine major neurocognitive disorder (like Alzheimer disease) include a more rapid onset (often following a stressor, such as losing driving privileges), intense distress or complaints about memory loss, and a characteristic lack of effort on cognitive testing. Instead of attempting to answer and making mistakes, depressed patients typically sigh, give up easily, or answer 'I do not know.' Furthermore, the patient's pervasive inactivity and significant weight loss are classic neurovegetative symptoms that confirm a major depressive episode.

Step-by-Step Solution

1
Identify the psychosocial stressor and timeline.
The patient lost his driver's license 5 months ago, correlating with the subacute onset of his symptoms.
A clear precipitating event with a subacute onset of cognitive complaints strongly suggests a psychiatric etiology rather than an insidious neurodegenerative disease.
2
Evaluate the patient's attitude toward his cognitive deficits.
He complains that his memory is 'completely gone' and refuses to try during the cognitive assessment.
Patients with depression-related cognitive impairment (pseudodementia) typically emphasize their deficits and show poor effort, unlike patients with genuine dementia who often lack insight and attempt to cover up their mistakes.
3
Look for neurovegetative symptoms of depression.
The patient exhibits severe anhedonia (sitting in a recliner all day) and a 10-lb weight loss.
These somatic symptoms confirm the presence of a major depressive episode.

Key Concept

Major depressive disorder in the elderly can present with prominent cognitive complaints (pseudodementia). It is differentiated from genuine major neurocognitive disorder by a subacute onset, exaggerated complaints about memory loss, poor effort on cognitive testing, and concurrent vegetative symptoms of depression.
Question 353Question →

A 25-year-old primigravida at 14 weeks gestation is evaluated in the emergency department for sudden-onset palpitations, chest tightness, trembling, and a feeling of impending doom that awoke her from sleep. The episode peaked within 10 minutes and has now resolved. She has had three similar unexpected episodes over the past month. She now refuses to leave her house unless accompanied by her husband, fearing she will have an attack in public. Medical history is notable for a hospitalization at age 19 for a manic episode with psychotic features; she had been stable on lithium but discontinued it 6 months prior to conception.

Her temperature is 37.0°C (98.6°F), blood pressure is 112/70 mm Hg, pulse is 92/min, and respirations are 18/min. Pulse oximetry is 99% on room air. She mentions a chronic, mild sensation of breathlessness over the last few weeks. Physical examination is unremarkable.

Laboratory results:
- TSH: 0.2 μ\mu IU/mL (normal: 0.4-4.0 μ\mu IU/mL)
- Free T 4_4: 1.3 ng/dL (normal: 0.8-1.8 ng/dL)

Arterial blood gas analysis on room air:
- pH: 7.45
- PaCO 2_2: 30 mm Hg
- PaO 2_2: 102 mm Hg

The patient's husband is distressed by her avoidance behaviors and demands she be given an intravenous sedative immediately. However, the patient explicitly declines any pharmacotherapy due to fear of teratogenicity. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Initiate cognitive-behavioral therapy

Answer

The most appropriate next step in management is to initiate cognitive-behavioral therapy.
Initiating cognitive-behavioral therapy is the most appropriate next step. The patient's clinical presentation of recurrent, unexpected episodes of intense fear accompanied by physical symptoms and subsequent avoidance behavior confirms a diagnosis of panic disorder with agoraphobia. Because she has a history of bipolar I disorder (which precludes standard SSRI monotherapy) and explicitly refuses pharmacotherapy due to her pregnancy, cognitive-behavioral therapy is the safest and most effective first-line, evidence-based intervention.

Step-by-Step Solution

1
Diagnose the patient's primary psychiatric condition based on the clinical presentation.
The patient has recurrent, unexpected episodes of intense fear with physical symptoms and subsequent avoidance behavior, confirming a diagnosis of Panic Disorder with Agoraphobia.
Accurate diagnosis is required before selecting a treatment modality.
2
Evaluate the patient's comorbidities and their impact on standard treatment options.
The patient has a history of Bipolar I Disorder. This contraindicates the use of SSRI or SNRI monotherapy, which are standard pharmacological treatments for panic disorder, due to the high risk of precipitating a manic switch.
Pharmacological interventions must be safe given the patient's full psychiatric history.
3
Assess the objective laboratory and physiological data to rule out medical mimics.
The mild dyspnea, isolated slightly low TSH, and compensated respiratory alkalosis are all normal physiologic changes of pregnancy. No urgent medical intervention is required for these findings.
It is crucial to differentiate between pathological states (e.g., hyperthyroidism, pulmonary embolism) and normal pregnancy physiology to avoid unnecessary interventions.
4
Incorporate the patient's preferences and ethical principles into the management plan.
The patient is competent and explicitly refuses pharmacotherapy. Her autonomy must be respected, pointing clearly to an evidence-based non-pharmacological treatment.
Patient autonomy allows competent patients to refuse any treatment, guiding the provider toward the best acceptable alternative.

Key Concept

Cognitive-behavioral therapy is the safest and most appropriate first-line treatment for panic disorder in a pregnant patient who has a history of bipolar disorder and who refuses pharmacotherapy.
Estimated Time:1m 30s
Question 354Question →

A 46-year-old female accountant is referred to the outpatient psychiatry clinic due to an 8-month history of excessive, uncontrollable worry regarding her finances, job security, and health. She describes feeling constantly "on edge," suffers from severe muscle tension in her neck and shoulders, and struggles with initial insomnia. These symptoms began shortly after she underwent a lumpectomy and localized radiation for estrogen receptor-positive, human epidermal growth factor receptor 2 (HER2)-negative breast cancer. She is currently taking tamoxifen and frequently complains of bothersome, spontaneous hot flashes occurring both during the day and at night. Vital signs are within normal limits. Which of the following is the most appropriate pharmacotherapy for this patient's psychiatric condition?

Show answer & explanation

Answer: Venlafaxine

Answer

The correct answer is Venlafaxine.
This patient meets the DSM-5 criteria for Generalized Anxiety Disorder (GAD), presenting with more than 6 months of excessive worry associated with feeling "on edge," muscle tension, and insomnia. Furthermore, she is experiencing tamoxifen-induced vasomotor symptoms (hot flashes). Venlafaxine, a serotonin-norepinephrine reuptake inhibitor (SNRI), is the ideal choice. It is a first-line pharmacotherapy for GAD and is highly efficacious in reducing both the frequency and severity of vasomotor symptoms. Most importantly, venlafaxine exerts minimal to no inhibitory effect on the cytochrome P450 2D6 (CYP2D6) enzyme. Tamoxifen is a prodrug that requires activation by CYP2D6 to form its highly active metabolite, endoxifen. Therefore, venlafaxine safely treats both her GAD and hot flashes without compromising the efficacy of her breast cancer adjuvant therapy.

Step-by-Step Solution

1
Diagnose the primary psychiatric condition based on the clinical presentation.
The patient has Generalized Anxiety Disorder (GAD), characterized by >6 months of excessive worry and at least 3 somatic symptoms (feeling on edge, muscle tension, insomnia).
Establishing the diagnosis determines the appropriate class of psychiatric medications (SSRIs or SNRIs).
2
Identify concurrent medical conditions and active pharmacological treatments.
The patient has a history of ER-positive breast cancer, is actively taking tamoxifen, and suffers from severe vasomotor symptoms (hot flashes).
Psychiatric medication selection must account for drug-drug interactions and aim to treat comorbid symptoms if possible.
3
Analyze the metabolic pathway of tamoxifen and the interaction profiles of potential psychotropics.
Tamoxifen is a prodrug requiring activation by the hepatic enzyme CYP2D6 to its active metabolite, endoxifen. Strong CYP2D6 inhibitors must be avoided.
Inhibiting CYP2D6 reduces the oncologic efficacy of tamoxifen, significantly increasing the risk of cancer recurrence.
4
Select the optimal agent that treats GAD, alleviates hot flashes, and lacks CYP2D6 inhibition.
Venlafaxine is selected because it is first-line for GAD, highly effective for vasomotor symptoms, and has minimal to no CYP2D6 inhibitory effects.
This single agent safely addresses both her psychiatric and somatic complaints without compromising her breast cancer treatment.

Key Concept

In patients taking tamoxifen, the management of Generalized Anxiety Disorder (GAD) and vasomotor symptoms requires the selection of an SSRI/SNRI with minimal CYP2D6 inhibition (e.g., venlafaxine, escitalopram) to avoid blocking the conversion of tamoxifen into its active metabolite, endoxifen.
Estimated Time:2m 0s
Question 355Question →

Evaluate the clinical scenarios below and match each patient to the most appropriate next step in psychiatric management.

Click a left item, then click its matching right item

Items

A 31-year-old primigravida at 14 weeks gestation is brought for urgent psychiatric evaluation. She exhibits profound psychomotor retardation and a steadfast, delusional belief that her internal organs are decomposing. She has refused all food and fluids for five days and appears severely dehydrated.
An otherwise healthy 24-year-old woman seeks help for a two-month history of sleeping 14 hours a day, hyperphagia, and severe depressed mood. Her medical history reveals a hospitalization three years ago following a two-week period of sleeplessness, pressured speech, and grandiose delusions. She currently takes no medications.
Three weeks following an anterior ST-elevation myocardial infarction complicated by heart failure, a 58-year-old man develops pervasive sadness, feelings of worthlessness, and passive suicidal ideation that severely impacts his cardiac rehabilitation.
A 52-year-old man with chronic, severe depression presents for consultation. He continues to experience debilitating anhedonia despite documented, adequate therapeutic trials of escitalopram, duloxetine, and venlafaxine augmented with aripiprazole. He adamantly refuses electroconvulsive therapy due to fears of memory impairment.

Matches

Show answer & explanation

Answer

The pregnant patient with inanition requires inpatient admission and ECT. The 24-year-old woman with a history of mania requires quetiapine monotherapy. The post-MI patient should be started on sertraline. The patient with treatment-resistant depression refusing ECT should receive intranasal esketamine.
Each correct pairing matches a nuanced psychiatric presentation with its safest and most evidence-based management strategy. ECT provides the rapid response required for inanition in pregnancy. Quetiapine treats bipolar depression without risking manic switch. Sertraline provides cardiac safety post-MI. Esketamine bypasses treatment resistance when ECT is refused.

Step-by-Step Solution

1
Analyze the pregnant patient's presentation (Left 1).
Identified psychotic depression with life-threatening inanition and fluid refusal.
Determines the need for rapid, safe intervention (ECT) over slower-acting pharmacotherapy, prioritizing fetal and maternal survival.
2
Evaluate the 24-year-old woman's history (Left 2).
Recognized a current depressive episode in the context of a past hospitalized manic episode (Bipolar I disorder).
Avoids the critical error of prescribing antidepressant monotherapy, guiding the choice toward bipolar-specific treatments like quetiapine.
3
Assess the 58-year-old man's medical comorbidities (Left 3).
Identified major depressive disorder occurring post-myocardial infarction.
Dictates the selection of a cardiac-safe antidepressant with low potential for CYP450 interactions, making sertraline the optimal choice.
4
Review the 52-year-old man's treatment history (Left 4).
Confirmed treatment-resistant depression (failed >2 classes) with a specific refusal of electroconvulsive therapy.
Guides the selection of advanced TRD therapies, specifically intranasal esketamine, which is evidence-based for this exact presentation.

Key Concept

Management of depressive disorders requires tailoring interventions to specific subtypes (e.g., psychotic features), identifying bipolar vs. unipolar disease to avoid manic switch, ensuring cardiovascular safety in comorbid patients, and escalating to interventional therapies for treatment resistance.
Question 356Question →

A 32-year-old man is evaluated in the psychiatric clinic as part of a court-mandated diversion program following an arrest for assault. During the interview, the patient is superficially charming but shows no remorse for his actions, stating, 'The guy was asking for it.' His medical records show a history of conduct disorder diagnosed at age 14, multiple arrests for theft, and chronic deceitfulness. He is currently prescribed fluoxetine by his primary care physician for mild depressive symptoms. He frequently demands early refills of controlled substances from various providers, although none are currently prescribed. He mentions that during periods of extreme frustration, he occasionally feels 'paranoid that people are out to get me' for a few days, but these feelings quickly resolve. Which of the following are the most appropriate considerations in the evaluation and management of this patient? (Select 2 choices)

Select all that apply

Show answer & explanation

Answer: Implementation of strict clinical boundaries and avoidance of prescribing medications with high abuse potential; Evaluation and treatment of common comorbid conditions, such as substance use disorders

Answer

The correct steps are implementing strict clinical boundaries with avoidance of abuse-potential medications, and evaluating for comorbid substance use disorders.
The patient's history of conduct disorder, deceitfulness, recurrent arrests, and lack of remorse are diagnostic of antisocial personality disorder (ASPD). There is no definitive pharmacological or psychotherapeutic cure for ASPD. Therefore, the standard of care focuses on managing the clinical relationship and addressing treatable comorbidities. Patients with ASPD frequently exhibit drug-seeking behavior and manipulation; thus, providers must establish firm, consistent boundaries and avoid prescribing medications with high abuse potential (e.g., benzodiazepines, stimulants). Additionally, patients with ASPD have a high prevalence of comorbid substance use and mood disorders, making the evaluation and treatment of these comorbidities a critical component of their overall care.

Step-by-Step Solution

1
Identify the primary personality disorder diagnosis.
The patient exhibits a pervasive pattern of disregard for others, lack of remorse, deceitfulness, and a history of conduct disorder before age 15. This confirms Antisocial Personality Disorder (ASPD).
Establishing the diagnosis guides the therapeutic approach and sets expectations for patient behavior.
2
Determine appropriate management strategies for ASPD.
Management involves setting strict, non-punitive boundaries, declining requests for medications with abuse potential, and treating comorbid conditions like substance use disorder.
ASPD has no specific pharmacological cure, and patients frequently display drug-seeking behavior. Addressing treatable comorbidities offers the best clinical outcome.
3
Rule out contraindicated pharmacological interventions.
Adding a monoamine oxidase inhibitor (MAOI) is rejected.
The patient is currently taking fluoxetine (an SSRI). Combining these medications risks life-threatening serotonin syndrome.
4
Exclude incorrect psychiatric diagnoses based on timeline and symptom severity.
Schizophreniform disorder is ruled out.
The patient's paranoid feelings are transient (lasting only a few days). Schizophreniform disorder requires psychotic symptoms to be present for at least one month.
5
Assess ethical obligations regarding confidentiality.
Notifying the employer is deemed inappropriate.
There is no specific, imminent threat to a third party that justifies overriding patient confidentiality.

Key Concept

Antisocial Personality Disorder Evaluation and Management
Question 357Question →

Match each clinical presentation of a breast disorder to the most appropriate initial diagnostic workup or management step.

Click a left item, then click its matching right item

Items

22-year-old woman with a newly discovered 2-cm firm, mobile, well-circumscribed palpable breast mass
32-year-old woman with bilateral, multi-ductal milky nipple discharge and no palpable breast masses
45-year-old woman with a new 3-cm firm, poorly circumscribed, painless palpable breast mass
26-year-old exclusively breastfeeding woman with fever, localized breast erythema, and a fluctuant, tender 4-cm mass

Matches

Show answer & explanation

Answer

Left 1 matches with Targeted breast ultrasound; Left 2 matches with Serum prolactin, TSH, and pregnancy testing; Left 3 matches with Diagnostic mammography and targeted breast ultrasound; Left 4 matches with Needle aspiration and empiric antibiotic therapy.
Each clinical scenario corresponds to a specific, guideline-directed management pathway based on age, symptom characteristics, and reproductive status.

Step-by-Step Solution

1
Evaluate the 22-year-old patient with a palpable breast mass.
Determine that the patient's age (< 30 years) necessitates targeted breast ultrasound as the first-line imaging.
Dense breast tissue in younger women lowers mammographic sensitivity and increases radiation risks, making ultrasound the standard initial test.
2
Assess the 32-year-old patient with milky nipple discharge.
Recognize this as physiologic galactorrhea, requiring endocrine evaluation before any imaging.
Bilateral, multiductal, milky discharge without a mass is rarely malignant and is typically driven by hormonal abnormalities.
3
Evaluate the 45-year-old patient with a palpable breast mass.
Select diagnostic mammography and targeted breast ultrasound.
For women aged 30 and older, both modalities are used to fully characterize the mass and screen for synchronous lesions in the ipsilateral or contralateral breast.
4
Evaluate the 26-year-old breastfeeding patient with a fluctuant mass and fever.
Identify a breast abscess and select needle aspiration with empiric antibiotics.
A localized, fluctuant collection in the setting of mastitis indicates an abscess that must be mechanically drained and treated with antibiotics targeting skin flora.

Key Concept

The initial evaluation of breast symptoms strictly depends on patient age (ultrasound for <30 vs. mammogram + ultrasound for >=30), the physiologic vs. pathologic nature of nipple discharge, and identifying signs of localized infection requiring drainage.
Question 358Question →

Match each clinical presentation of cognitive decline to its most likely underlying pathophysiologic mechanism.

Click a left item, then click its matching right item

Items

A 67-year-old man presents with a 3-month history of rapidly progressive memory loss, akinetic mutism, and sudden, brief muscle jerks elicited by loud noises.
A 59-year-old woman exhibits a 2-year history of socially inappropriate comments, compulsive consumption of sweets, and profound apathy, with preserved visuospatial skills.
A 74-year-old man develops progressive cognitive impairment, pronounced fluctuations in daytime alertness, vivid hallucinations of animals, and a new-onset resting tremor.
A 71-year-old woman with a long-standing history of medication-noncompliant hypertension experiences abrupt declines in executive function separated by periods of stability, along with a right-sided Babinski sign.
A 76-year-old man presents with an insidious onset of a broad-based, magnetic gait, urinary urgency culminating in incontinence, and generalized cognitive slowing over 8 months.

Matches

Show answer & explanation

Answer

The correct pairings match Creutzfeldt-Jakob disease to prion misfolding, frontotemporal dementia to tau/TDP-43 accumulation, Lewy body dementia to alpha-synuclein inclusions, vascular dementia to ischemic white matter injury, and normal pressure hydrocephalus to impaired cerebrospinal fluid reabsorption.
Each clinical vignette provides classic hallmark features of a specific neurocognitive disorder, which directly corresponds to a unique pathophysiologic mechanism. Creutzfeldt-Jakob disease is caused by prion misfolding. Frontotemporal dementia is caused by tau or TDP-43 inclusions. Lewy body dementia is caused by alpha-synuclein aggregation. Vascular dementia is caused by ischemic white matter injury from small vessel disease. Normal pressure hydrocephalus is caused by impaired cerebrospinal fluid reabsorption leading to ventricular expansion.

Step-by-Step Solution

1
Analyze the first clinical presentation (rapid cognitive decline, startle myoclonus).
Identify Creutzfeldt-Jakob disease.
Recognize the classic triad of rapidly progressive dementia, myoclonus, and akinetic mutism.
2
Analyze the second presentation (social disinhibition, hyperorality).
Identify behavioral variant frontotemporal dementia.
Note the early personality changes and compulsive behaviors with relatively spared memory.
3
Analyze the third presentation (fluctuations, visual hallucinations, parkinsonism).
Identify Lewy body dementia.
Recognize the core criteria for this specific alpha-synucleinopathy.
4
Analyze the fourth presentation (stepwise decline, asymmetric reflexes).
Identify vascular dementia.
Note the temporal relationship with vascular risk factors (hypertension) and focal neurologic findings.
5
Analyze the fifth presentation (magnetic gait, incontinence, cognitive slowing).
Identify normal pressure hydrocephalus.
Recognize the classic triad of wacky, wobbly, and wet.
6
Match each identified syndrome to its underlying pathophysiology.
Map each clinical entity to its defining cellular or macroscopic mechanism.
To complete the matching set correctly by connecting clinical diagnoses with their established etiologies.

Key Concept

Distinct clinical presentations of neurocognitive disorders directly correlate with specific pathophysiologic mechanisms, such as abnormal protein aggregations or structural brain changes.
Question 359Question →

A 58-year-old woman is admitted to the hospital for management of a deep vein thrombosis. A psychiatric consultation is requested because she refuses her prescribed heparin infusion. The patient states she has a "sixth sense" that hospital medications contain micro-crystals designed to negatively alter her aura. She has lived alone in a rural cabin for 30 years, making a living selling energy-infused stones online. During the interview, she speaks in a vague, overly elaborate manner and appears highly anxious around the nursing staff, attributing her fear to their "disruptive energy fields." Collateral history from her visiting sister confirms that the patient has exhibited these eccentric beliefs and a preference for intense isolation since her early 20s. The sister also notes the patient has experienced fatigue and poor sleep over the past two weeks due to leg pain. Frustrated by the situation, the sister demands that the physician administer the heparin regardless of the patient's objections to prevent a pulmonary embolism.

Which of the following statements regarding the diagnosis and management of this patient are correct? (Select all that apply)

Select all that apply

Show answer & explanation

Answer: The patient's lifelong pattern of social deficits, magical thinking, and eccentric behavior without frank psychosis indicates a Cluster A personality disorder.; The treatment team should adopt a professional, straightforward communication style, respecting her need for emotional distance to build therapeutic rapport.

Answer

The correct statements recognize that the patient's lifelong eccentricities point to a Cluster A personality disorder, and that the medical team should respect her need for emotional distance to build therapeutic rapport.
Schizotypal personality disorder is defined by a pervasive pattern of eccentric behavior, magical thinking, odd speech, and intense social anxiety that does not improve with familiarity. These traits must be present since early adulthood and occur independently of a primary psychotic disorder. Management of these patients in a medical setting requires a professional, non-intrusive approach to minimize their inherent paranoia and build sufficient trust for medical interventions.

Step-by-Step Solution

1
Analyze the psychiatric presentation and timeline.
The patient exhibits magical thinking ('sixth sense', 'auras'), odd speech, and social anxiety dating back to early adulthood.
Establishing the onset and nature of symptoms is necessary to differentiate personality disorders from primary psychotic disorders.
2
Differentiate from primary psychotic and mood disorders.
The patient lacks true fixed delusions or hallucinations (ruling out schizophrenia) and her acute fatigue is linked to physical illness, not bipolar depression.
Schizophrenia requires at least 1 month of active-phase psychosis. Misdiagnosing mood symptoms could lead to inappropriate pharmacological interventions, such as dangerous SSRI monotherapy in bipolar disorder.
3
Evaluate the ethical conflict regarding medical decision-making.
The patient's psychiatric diagnosis does not automatically invalidate her capacity to refuse heparin.
Capacity must be individually assessed based on understanding and reasoning. Bypassing a capacitated patient for a surrogate decision-maker is an ethical violation.
4
Determine the optimal management strategy.
The most effective approach is to maintain professional boundaries and respect her need for interpersonal distance.
Patients with schizotypal personality disorder experience severe anxiety with close interpersonal contact; a neutral, clear approach prevents worsening paranoia and facilitates medical care.

Key Concept

Diagnosis of Schizotypal Personality Disorder requires recognizing lifelong patterns of magical thinking and social deficits, differentiating them from primary psychotic disorders, and managing patients with clear boundaries without inappropriately assuming a lack of decision-making capacity.
Estimated Time:2m 0s
Question 360Question →

Match each clinical vignette describing a medication-specific complication, adverse effect, or pharmacokinetic requirement to the most likely offending psychotropic agent used in the context of bipolar disorder.

Click a left item, then click its matching right item

Items

A 28-year-old woman treated for bipolar I disorder presents with amenorrhea and bilateral galactorrhea. Laboratory evaluation reveals a negative serum beta-hCG and an elevated serum prolactin level.
A 45-year-old man on maintenance pharmacotherapy for bipolar disorder is found to have a serum sodium of 124 mEq/L (normal: 135-145) on routine lab monitoring. He is clinically euvolemic, and his urine osmolality is elevated.
A 32-year-old man is prescribed a second-generation antipsychotic for acute bipolar depression. To ensure adequate systemic absorption and therapeutic efficacy, the physician instructs him to take the medication with a meal of at least 350 calories.
A 50-year-old man on long-term maintenance therapy complains of excessive thirst and urinating 6 to 8 liters per day. His urine specific gravity is low, and his symptoms do not improve after a period of water deprivation.
A 24-year-old woman with a history of recurrent severe depression and a first-degree relative with bipolar disorder is prescribed a selective serotonin reuptake inhibitor. Two weeks later, she requires hospitalization for severe agitation, pressured speech, and a decreased need for sleep.

Matches

Show answer & explanation

Answer

The correct matches are: Galactorrhea and amenorrhea with Risperidone; Euvolemic hyponatremia with Carbamazepine; Required administration with a 350-calorie meal with Lurasidone; Nephrogenic diabetes insipidus with Lithium carbonate; and Antidepressant-induced manic switch with Fluoxetine.
Each medication utilized in bipolar disorder management has a distinct profile. Risperidone is highly associated with hyperprolactinemia. Carbamazepine causes SIADH (hyponatremia). Lurasidone necessitates administration with significant food (>350 calories) for absorption. Lithium causes nephrogenic diabetes insipidus by antagonizing ADH. Fluoxetine, an SSRI, can induce an acute manic episode if given as monotherapy to a patient with bipolar disorder.

Step-by-Step Solution

1
Analyze the endocrine/reproductive vignette.
Identified hyperprolactinemia.
Among the options, Risperidone is the antipsychotic most strongly associated with tuberoinfundibular dopamine blockade and subsequent elevated prolactin.
2
Analyze the electrolyte abnormality vignette.
Identified euvolemic hyponatremia consistent with SIADH.
Carbamazepine frequently causes SIADH, requiring routine serum sodium monitoring.
3
Analyze the pharmacokinetic vignette.
Identified the specific caloric intake requirement for absorption.
Lurasidone specifically requires a minimum 350-calorie meal for adequate bioavailability; taking it on an empty stomach drastically reduces its efficacy.
4
Analyze the renal/urinary vignette.
Identified nephrogenic diabetes insipidus.
Lithium carbonate is a classic cause of acquired nephrogenic DI due to its interference with ADH action at the collecting duct, leading to massive polyuria and polydipsia.
5
Analyze the psychiatric complication vignette.
Identified an antidepressant-induced manic switch.
Fluoxetine, a selective serotonin reuptake inhibitor, should not be used as monotherapy for depression in patients with a history of or high risk for bipolar disorder due to the risk of precipitating mania.

Key Concept

Pharmacotherapy for Bipolar Disorder: Specific Adverse Effects and Administration Requirements
PreviousPage 18 / 414Next
All practice questions — USMLE Step 2 CK | Examkin